SMITH IAN F — SEC insider filings
SEC reporting owner CIK 1197032. 43 insider filings on record with FilingPulse; latest filed 2026-10-06.
Transaction summary — filings shown
Covers all 43 filings on record, filed 2020-12-14 to 2026-10-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 74.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | Director | 29 | — | — | 58 |
| Foghorn Therapeutics Inc. (FHTX) | Director | 8 | — | — | 8 |
| Stoke Therapeutics, Inc. (STOK) | Chief Executive Officer, Director | 5 | — | — | 7 |
| Odyssey Therapeutics, Inc. (ODTX) | Director | 1 | — | — | 1 |
Insider filings — SMITH IAN F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,440 · Option exercise (M): 3,440 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,440 · Option exercise (M): 3,440 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 28,000 (derivative) @ $4.08 | EDGAR |
| 2026-06-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 77,500 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Odyssey Therapeutics, Inc. (ODTX) | Grant/award (A): 27,393 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,441 · Option exercise (M): 3,441 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 193,000 (derivative) @ $0 · Grant/award (A): 129,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 4,573 · Grant/award (A): 18,012 (derivative) @ $0 · Grant/award (A): 13,761 (derivative) @ $0 · Option exercise (M): 4,573 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 570,000 (derivative) @ $0 · Grant/award (A): 380,000 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 4,573 · Option exercise (M): 4,573 (derivative) @ $0 | EDGAR |
| 2025-07-08 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 4,573 · Option exercise (M): 4,573 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 25,000 (derivative) @ $4.79 | EDGAR |
| 2025-06-13 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 77,500 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 4,574 · Option exercise (M): 4,574 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 238,420 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,255 · Option exercise (M): 3,255 (derivative) @ $0 · Grant/award (A): 22,148 (derivative) @ $0 · Grant/award (A): 18,293 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,255 · Option exercise (M): 3,255 (derivative) @ $0 | EDGAR |
| 2024-07-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,255 · Option exercise (M): 3,255 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $5.52 | EDGAR |
| 2024-06-13 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 34,400 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 7,639 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 3,256 · Option exercise (M): 3,256 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 15,570 · Option exercise (M): 15,570 (derivative) @ $0 · Grant/award (A): 15,112 (derivative) @ $0 · Grant/award (A): 13,021 (derivative) @ $0 | EDGAR |
| 2023-12-12 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 26,977 (derivative) @ $0 | EDGAR |
| 2023-10-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 15,569 · Option exercise (M): 15,569 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 96,340 (derivative) @ $0 | EDGAR |
| 2023-07-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 15,570 · Option exercise (M): 15,570 (derivative) @ $0 | EDGAR |
| 2023-06-22 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 15,569 · Option exercise (M): 15,569 (derivative) @ $0 · Grant/award (A): 9,650 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 1,620 · Option exercise (M): 1,620 (derivative) @ $0 · Option exercise (M): 70,796 (derivative) @ $0 · Grant/award (A): 62,278 (derivative) @ $0 | EDGAR |
| 2022-12-15 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 9,650 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 13,172 | EDGAR |
| 2022-10-04 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 24,312 · Option exercise (M): 24,312 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 24,313 · Option exercise (M): 24,313 (derivative) @ $0 | EDGAR |
| 2022-06-22 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 51,000 (derivative) @ $0 | EDGAR |
| 2022-04-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 24,313 · Option exercise (M): 24,313 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 194,500 (derivative) @ $0 · Grant/award (A): 97,250 (derivative) @ $0 | EDGAR |
| 2021-06-24 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 12,530 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-04-29 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 25,060 (derivative) @ $11.50 | EDGAR |
| 2021-01-06 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 389,000 (derivative) @ $0 | EDGAR |
| 2020-12-14 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 270,270 @ $3.70 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197032 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs